Byhealth Future Growth
Future criteria checks 3/6
Byhealth is forecast to grow earnings and revenue by 23.9% and 13.2% per annum respectively. EPS is expected to grow by 23.9% per annum. Return on equity is forecast to be 15.3% in 3 years.
Key information
23.9%
Earnings growth rate
23.9%
EPS growth rate
| Personal Products earnings growth | 20.2% |
| Revenue growth rate | 13.2% |
| Future return on equity | 15.3% |
| Analyst coverage | Good |
| Last updated | 06 Aug 2024 |
Recent future growth updates
Recent updates
Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel
Jul 26
Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital
May 23We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings
Mar 25Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,877 | 2,208 | 2,084 | 2,258 | 6 |
| 12/31/2025 | 10,560 | 1,865 | 1,343 | 1,966 | 7 |
| 12/31/2024 | 9,497 | 1,632 | 26 | 1,497 | 6 |
| 6/30/2024 | 8,424 | 1,092 | 995 | 1,306 | N/A |
| 3/31/2024 | 8,945 | 1,443 | 223 | 1,535 | N/A |
| 12/31/2023 | 9,407 | 1,746 | 794 | 2,051 | N/A |
| 9/30/2023 | 9,484 | 1,805 | 666 | 1,938 | N/A |
| 6/30/2023 | 9,237 | 1,883 | 818 | 2,075 | N/A |
| 3/31/2023 | 8,689 | 1,752 | 1,833 | 2,090 | N/A |
| 12/31/2022 | 7,861 | 1,386 | 1,134 | 1,379 | N/A |
| 9/30/2022 | 7,563 | 1,573 | 1,404 | 1,645 | N/A |
| 6/30/2022 | 7,454 | 1,431 | 1,170 | 1,430 | N/A |
| 3/31/2022 | 7,489 | 1,601 | 1,468 | 1,721 | N/A |
| 12/31/2021 | 7,431 | 1,754 | 1,556 | 1,819 | N/A |
| 9/30/2021 | 7,091 | 1,720 | 1,000 | 1,267 | N/A |
| 6/30/2021 | 7,168 | 1,934 | 1,299 | 1,534 | N/A |
| 3/31/2021 | 6,822 | 1,806 | 1,236 | 1,573 | N/A |
| 12/31/2020 | 6,095 | 1,524 | 1,245 | 1,566 | N/A |
| 9/30/2020 | 5,914 | -80 | 1,733 | 2,039 | N/A |
| 6/30/2020 | 5,417 | -261 | 1,485 | 1,821 | N/A |
| 3/31/2020 | 5,186 | -319 | 1,319 | 1,576 | N/A |
| 12/31/2019 | 5,262 | -356 | 1,205 | 1,537 | N/A |
| 9/30/2019 | 5,310 | 1,132 | 880 | 1,192 | N/A |
| 6/30/2019 | 5,151 | 1,161 | 974 | 1,238 | N/A |
| 3/31/2019 | 4,854 | 1,125 | 905 | 1,234 | N/A |
| 12/31/2018 | 4,351 | 999 | 1,098 | 1,349 | N/A |
| 9/30/2018 | 4,182 | 1,018 | 968 | 1,226 | N/A |
| 6/30/2018 | 3,794 | 885 | 827 | 1,084 | N/A |
| 3/31/2018 | 3,442 | 852 | N/A | 951 | N/A |
| 12/31/2017 | 3,111 | 763 | N/A | 954 | N/A |
| 9/30/2017 | 2,747 | 771 | N/A | 809 | N/A |
| 6/30/2017 | 2,562 | 759 | N/A | 772 | N/A |
| 3/31/2017 | 2,389 | 594 | N/A | 694 | N/A |
| 12/31/2016 | 2,309 | 535 | N/A | 685 | N/A |
| 9/30/2016 | 2,398 | 619 | N/A | 710 | N/A |
| 6/30/2016 | 2,322 | 577 | N/A | 583 | N/A |
| 3/31/2016 | 2,344 | 655 | N/A | 613 | N/A |
| 12/31/2015 | 2,266 | 635 | N/A | 635 | N/A |
| 9/30/2015 | 2,101 | 609 | N/A | 606 | N/A |
| 6/30/2015 | 1,944 | 566 | N/A | 624 | N/A |
| 3/31/2015 | 1,806 | 530 | N/A | 572 | N/A |
| 12/31/2014 | 1,705 | 503 | N/A | 561 | N/A |
| 9/30/2014 | 1,704 | 547 | N/A | 674 | N/A |
| 6/30/2014 | 1,668 | 542 | N/A | 764 | N/A |
| 3/31/2014 | 1,594 | 481 | N/A | 707 | N/A |
| 12/31/2013 | 1,482 | 422 | N/A | 627 | N/A |
| 9/30/2013 | 1,420 | 392 | N/A | 329 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300146's forecast earnings growth (23.9% per year) is above the savings rate (2.9%).
Earnings vs Market: 300146's earnings (23.9% per year) are forecast to grow faster than the CN market (22% per year).
High Growth Earnings: 300146's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300146's revenue (13.2% per year) is forecast to grow slower than the CN market (13.5% per year).
High Growth Revenue: 300146's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300146's Return on Equity is forecast to be low in 3 years time (15.3%).